Literature DB >> 1329906

Cell and membrane lipid analysis by proton magnetic resonance spectroscopy in five breast cancer cell lines.

L Le Moyec1, R Tatoud, M Eugène, C Gauvillé, I Primot, D Charlemagne, F Calvo.   

Abstract

The lipid composition of five human breast cancer cell lines (MCF-7, T47D, ZR-75-1, SKBR3 and MDA-MB231) was assessed by proton magnetic resonance spectroscopy (MRS) in whole cells and membrane-enriched fractions. The proportions of the three main lipid resonances in 1D spectra were different for each cell line. These resonances included mobile methyl and methylene functions from fatty acids of triglycerides and phospholipids and N-trimethyl from choline of phospholipids. T47D and ZR-75-1 cells presented a high methylene/methyl ratio (6.02 +/- 0.35 and 6.28 +/- 0.90). This ratio was significantly lower for SKBR3, MCF-7 and MDA-MB231 cells (2.76 +/- 0.22, 2.27 +/- 0.57 and 1.39 +/- 0.39). The N-trimethyl/methyl ratio was high for MDA-MB231 and SKBR3 cells (1.38 +/- 0.54 and 0.86 +/- 0.32), but lower for MCF-7, T47D and ZR-75-1 cells (0.49 +/- 0.11, 0.16 +/- 0.07 and 0.07 +/- 0.03). 2D COSY spectra confirmed these different proportions in mobile lipids. From 1D spectra obtained on membrane preparations, T47D and ZR-75-1 were the only cell lines to retain a signal from mobile methylene functions. These differences might be related to the heterogeneity found for several parameters of these cells (tumorigenicity, growth rate, hormone receptors); an extended number of cases from fresh samples might enable clinical correlations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329906      PMCID: PMC1977411          DOI: 10.1038/bjc.1992.327

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Development of the "activated" high resolution 1H MR spectrum in murine T cells and B cells occurs in G1 phase of the cell cycle.

Authors:  K T Holmes; C L Lean; N H Hunt; N J King
Journal:  Magn Reson Med       Date:  1990-10       Impact factor: 4.668

2.  Complete separation of intracellular and extracellular information in NMR spectra of perfused cells by diffusion-weighted spectroscopy.

Authors:  P C Van Zijl; C T Moonen; P Faustino; J Pekar; O Kaplan; J S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  Neural networks as a tool for utilizing laboratory information: comparison with linear discriminant analysis and with classification and regression trees.

Authors:  G Reibnegger; G Weiss; G Werner-Felmayer; G Judmaier; H Wachter
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

Review 4.  Human breast carcinoma cells in continuous culture: a review.

Authors:  L W Engel; N A Young
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

5.  Role of membrane lipids in the interaction of daunomycin with plasma membranes from tumor cells: implications in drug-resistance phenomena.

Authors:  P V Escriba; A V Ferrer-Montiel; J A Ferragut; J M Gonzalez-Ros
Journal:  Biochemistry       Date:  1990-08-07       Impact factor: 3.162

6.  Differences in lipid characteristics of undifferentiated and enterocytic-differentiated HT29 human colonic cells.

Authors:  M Reynier; H Sari; M d'Anglebermes; E A Kye; L Pasero
Journal:  Cancer Res       Date:  1991-02-15       Impact factor: 12.701

7.  N-6 polyunsaturated fatty acids in human breast carcinoma phosphatidylethanolamine and early relapse.

Authors:  M Lanson; P Bougnoux; P Besson; J Lansac; B Hubert; C Couet; O Le Floch
Journal:  Br J Cancer       Date:  1990-05       Impact factor: 7.640

8.  Continuous culture and soft agarose cloning of multiple human breast carcinoma cell lines in serum-free medium.

Authors:  F Calvo; M Brower; D N Carney
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

9.  Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism.

Authors:  O Kaplan; G Navon; R C Lyon; P J Faustino; E J Straka; J S Cohen
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

Review 10.  Biological and NMR markers for cancer.

Authors:  M Czuba; I C Smith
Journal:  Pharmacol Ther       Date:  1991       Impact factor: 12.310

View more
  7 in total

1.  Intramyocellular lipids versus intramyocellular triglycerides.

Authors:  Dequan Zhou; ZengKui Guo
Journal:  Magn Reson Med       Date:  2011-12-16       Impact factor: 4.668

Review 2.  MR-visible lipids and the tumor microenvironment.

Authors:  E James Delikatny; Sanjeev Chawla; Daniel-Joseph Leung; Harish Poptani
Journal:  NMR Biomed       Date:  2011-04-27       Impact factor: 4.044

3.  Artificial neural networks for classification in metabolomic studies of whole cells using 1H nuclear magnetic resonance.

Authors:  D F Brougham; G Ivanova; M Gottschalk; D M Collins; A J Eustace; R O'Connor; J Havel
Journal:  J Biomed Biotechnol       Date:  2010-09-15

4.  Cellular Lactate Spectroscopy Using 1.5 Tesla Clinical Apparatus.

Authors:  Adrian Truszkiewicz; Dorota Bartusik-Aebisher; Jolanta Zalejska-Fiolka; Aleksandra Kawczyk-Krupka; David Aebisher
Journal:  Int J Mol Sci       Date:  2022-09-26       Impact factor: 6.208

5.  Noninvasive estimation of tumour viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (1H MRS).

Authors:  M Lindskog; P Kogner; F Ponthan; P Schweinhardt; B Sandstedt; T Heiden; G Helms; C Spenger
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

6.  Pimonidazole binding in C6 rat brain glioma: relation with lipid droplet detection.

Authors:  S Zoula; P F J W Rijken; J P W Peters; R Farion; B P J Van der Sanden; A J Van der Kogel; M Décorps; C Rémy
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

7.  Use of neoadjuvant chemotherapy prior to radical hysterectomy in cervical cancer: monitoring tumour shrinkage and molecular profile on magnetic resonance and assessment of 3-year outcome.

Authors:  N M deSouza; W P Soutter; G Rustin; M M Mahon; B Jones; R Dina; G A McIndoe
Journal:  Br J Cancer       Date:  2004-06-14       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.